APOLLO HOSPITALS ENTER. L vs GLAND PHARMA LIMITED
A side-by-side comparison of APOLLO HOSPITALS ENTER. L (APOLLOHOSP) and GLAND PHARMA LIMITED (GLAND) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.
APOLLO HOSPITALS ENTER. L vs GLAND PHARMA LIMITED are evenly matched on the numbers (7–7). The breakdown below shows where each one wins.
- Valuation13
- Profitability22
- Growth11
- Size & financial health31
Each axis shows this group's split of that metric, scaled so the leader sits at the edge. Relative to each other, not an absolute score.
Valuation
GLAND takes 3/4How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.
Profitability
EvenHow efficiently each company turns capital and sales into profit. Higher is better.
Growth
EvenThree-year compounded growth. Faster-growing businesses can justify a higher valuation.
Size & financial health
APOLLOHOSP takes 3/4Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.
- + ["Company has delivered good profit growth of 76.2% CAGR over last 5 years", "Company has been maintaining a healthy dividend payout of 17.7%"]
- − ["Stock is trading at 13.4 times its book value", "Company might be capitalizing the interest cost"]
- + ["Company is almost debt free.", "Company has been maintaining a healthy dividend payout of 39.1%"]
- − ["Stock is trading at 4.59 times its book value", "Company has a low return on equity of 9.29% over last 3 years.", "Promoter holding has decreased over last 3 years: -6.09%"]
This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.